Press Releases -> Pharmaceuticals & Biotech Syndicate content

Feb 01, 2021

Partners Announce Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina

Jan 13, 2021

-Hanmi Pharmaceutical Co., Ltd. develops a full package strategy to handle the prevention, diagnosis, and potential treatment of COVID-19
-Recently releases Hanmi Cold-Mask™(nasal spray) and prepares to release COVID-19 & Influenza dual diagnostic kit

SEOUL, South Korea, Jan. 13, 2021 -- Hanmi...

Oct 11, 2020

Indonesia, hit hard by the coronavirus pandemic, has plans to establish itself as the Covid-19 vaccine research and development hub in Southeast Asia with support from China.

According to Indonesia’s coordinating minister for maritime affairs and investments, Luhut Pandjaitan, China is readily supporting the...

Sep 09, 2020

LIVERMORE, Calif. -- S2 Genomics, Inc., today announced that it has entered into distribution agreements with SCRUM, PharmiGene, LnCBio, Thunderbio Science, and TrendBio for the promotion, sales, and support of S2’s Singulator™ 100 System and associated products for single-cell genomics and cell biology...

Aug 27, 2020

HANGZHOU, China, Aug. 27, 2020 -- HJB, a biologics Contract Development and Manufacturing Organization (CDMO) committed to quality, reliability and speed for each and every CMC package delivered to its partners, announces it enters into a strategic partnership for CMC development and manufacturing with Ansun...

Aug 27, 2020

Collaboration with CGNNT to further strengthen access to the growing Chinese proton therapy market

Aug 17, 2020

TOKYO -- Financial executives at wealth management advisory Oita Chuo Pacific Management have commented on Sanofi S.A. agreeing to acquire U.S. biotech firm Principia Biopharma Inc. in a deal worth $3.4 billion, as the French drug manufacturer shifts towards innovative treatments to boost growth under latest Chief...

Aug 11, 2020

Researchers from the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) have recently conducted a study to investigate the impact of liver injury on clinical outcomes in COVID-19 patients. Data from over 1,000 COVID-19 patients in Hong Kong was analysed and liver injury was found in around 20...

Aug 01, 2020

First dose of ETC-159 administered in Phase 1B of clinical trials, advancing the development of this drug to treat solid tumours

Singapore – Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving “First Patient First Visit” in Phase 1B. The first dose of ETC-159 has...

Jul 25, 2020

SINGAPORE – MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency...

Jul 02, 2020

Polaris Biology and Tetramer Shop combine forces to accelerate state-of-the-art single-cell analysis capacity.

SHANGHAI, China and COPENHAGEN, Denmark, July 2, 2020 -- Today two MedTech companies, Polaris Biology of China and Tetramer Shop of Denmark, announce a strategic partnership to co-develop and...

Jun 23, 2020

A Hong Kong genetics start-up has devised a low-cost solution allowing screening for COVID-19 carriers and counts UK football stars among its clientele.

The rapid spread of COVID-19, which has infected more than eight million people across the planet and led to over 400,000 deaths, presents the world with an...

Jun 23, 2020

SINGAPORE--Sengenics, the Functional Proteomics Company, today announced the launch of ImmuSAFE™ COVID+, a multi-antigen, multi-domain, fully quantitative serology test. ImmuSAFE™ enables the determination of the target epitopes, titres and Ig class/sub-class (IgG, IgA, IgM; IgG1-4) of antibodies produced across...

Jun 22, 2020

EMB-01 is found to induce co-degradation of EGFR and cMet in various tumor cells

Jun 22, 2020

Audio recordings of scientific presentations explicate preclinical data for three novel antibody drug candidates in the HiFiBiO Therapeutics pipeline

May 10, 2020

Whether Taiwan should test everyone for COVID-19, regardless of contact history, is an ongoing debate.

On the flip side, Taiwan’s testing capacity is far behind that of Korea, whether in terms of labs or medical professionals. Even the number of test kits is insufficient.

For citizens who wish to pay...

Apr 23, 2020

SINGAPORE -- Sengenics, a functional proteomics company, today announced the product launch of a new KREX™-based array, the ImmuKyne™ protein array, in a bid to enhance and accelerate effective response for COVID-19 by understanding whether autoantibodies play a role in progression to severe disease in COVID-19...

Apr 16, 2020

Zhou Renjie captures the infinitesimal with his super microscope

Nothing spells out ‘Science Lab’ better than the image of a microscope. Together with the white lab coat, these are the stereotypical tools of a scientist’s trade.

But microscopes have come a long way since the days of our high school...

Apr 13, 2020

After close consideration with our partners from around the world, Informa Markets & IMPACT Exhibition Management Co., Ltd. - the organisers of Medlab Asia & Asia Health, has decided to postpone the event originally scheduled from the 10-12 June 2020, with the new dates confirmed for the 28-30 October 2020...

Apr 01, 2020

Modalis Therapeutics and Editas Medicine conclude license